{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Sfrp1", "Wnt/\u03b2-catenin signaling pathway", "diabetic nephropathy", "miRNA-27a", "renal fibrosis"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "32484208", "DateCompleted": {"Year": "2021", "Month": "03", "Day": "24"}, "DateRevised": {"Year": "2021", "Month": "03", "Day": "24"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": ["BSR20192794", "10.1042/BSR20192794"], "Journal": {"ISSN": "1573-4935", "JournalIssue": {"Volume": "40", "Issue": "6", "PubDate": {"Year": "2020", "Month": "Jun", "Day": "26"}}, "Title": "Bioscience reports", "ISOAbbreviation": "Biosci Rep"}, "ArticleTitle": "MicroRNA-27a targets Sfrp1 to induce renal fibrosis in diabetic nephropathy by activating Wnt/\u03b2-Catenin signalling.", "Abstract": {"AbstractText": ["Diabetic nephropathy (DN) commonly causes end-stage renal disease (ESRD). Increasing evidence indicates that abnormal miRNA expression is tightly associated with chronic kidney disease (CKD). This work aimed to investigate whether miR-27a can promote the occurrence of renal fibrosis in DN by suppressing the expression of secreted frizzled-related protein 1 (Sfrp1) to activate Wnt/\u03b2-catenin signalling. Therefore, we assessed the expression levels of miR-27a, Sfrp1, Wnt signalling components, and extracellular matrix (ECM)-related molecules in vitro and in vivo. Sfrp1 was significantly down-regulated in a high-glucose environment, while miR-27a levels were markedly increased. A luciferase reporter assay confirmed that miR-27a down-regulated Sfrp1 by binding to the 3' untranslated region directly. Further, NRK-52E cells under high-glucose conditions underwent transfection with miR-27a mimic or the corresponding negative control, miR-27a inhibitor or the corresponding negative control, si-Sfrp1, or combined miR-27a inhibitor and si-Sfrp1. Immunoblotting and immunofluorescence were performed to assess the relative expression levels of Wnt/\u03b2-catenin signalling and ECM components. The mRNA levels of Sfrp1, miR-27a, and ECM-related molecules were also detected by quantitative real-time PCR (qPCR). We found that miR-27a inhibitor inactivated Wnt/\u03b2-catenin signalling and reduced ECM deposition. Conversely, Wnt/\u03b2-catenin signalling was activated, while ECM deposition was increased after transfection with si-Sfrp1. Interestingly, miR-27a inhibitor attenuated the effects of si-Sfrp1. We concluded that miR-27a down-regulated Sfrp1 and activated Wnt/\u03b2-catenin signalling to promote renal fibrosis."], "CopyrightInformation": "\u00a9 2020 The Author(s)."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, Guizhou 550025, China."}, {"Identifier": [], "Affiliation": "Department of Pathophysiology, Guizhou Medical University, Guiyang, Guizhou 550025, China."}], "LastName": "Shi", "ForeName": "MingJun", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pathophysiology, Guizhou Medical University, Guiyang, Guizhou 550025, China."}, {"Identifier": [], "Affiliation": "Laboratory of Pathogenesis Research, Drug Prevention and Treatment of Major Diseases, Guizhou Medical University, Guiyang, Guizhou 550025, China."}], "LastName": "Tian", "ForeName": "PingPing", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pathophysiology, Guizhou Medical University, Guiyang, Guizhou 550025, China."}, {"Identifier": [], "Affiliation": "Laboratory of Pathogenesis Research, Drug Prevention and Treatment of Major Diseases, Guizhou Medical University, Guiyang, Guizhou 550025, China."}], "LastName": "Liu", "ForeName": "ZhongQiang", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pathophysiology, Guizhou Medical University, Guiyang, Guizhou 550025, China."}, {"Identifier": [], "Affiliation": "Laboratory of Pathogenesis Research, Drug Prevention and Treatment of Major Diseases, Guizhou Medical University, Guiyang, Guizhou 550025, China."}], "LastName": "Zhang", "ForeName": "Fan", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pathophysiology, Guizhou Medical University, Guiyang, Guizhou 550025, China."}, {"Identifier": [], "Affiliation": "Laboratory of Pathogenesis Research, Drug Prevention and Treatment of Major Diseases, Guizhou Medical University, Guiyang, Guizhou 550025, China."}], "LastName": "Zhang", "ForeName": "YingYing", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pathophysiology, Guizhou Medical University, Guiyang, Guizhou 550025, China."}, {"Identifier": [], "Affiliation": "Laboratory of Pathogenesis Research, Drug Prevention and Treatment of Major Diseases, Guizhou Medical University, Guiyang, Guizhou 550025, China."}], "LastName": "Qu", "ForeName": "LingLing", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Guizhou Provincial People's Hospital, Guiyang, Guizhou 550025, China."}], "LastName": "Liu", "ForeName": "XingMei", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pathophysiology, Guizhou Medical University, Guiyang, Guizhou 550025, China."}, {"Identifier": [], "Affiliation": "Laboratory of Pathogenesis Research, Drug Prevention and Treatment of Major Diseases, Guizhou Medical University, Guiyang, Guizhou 550025, China."}], "LastName": "Wang", "ForeName": "YuanYuan", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pathophysiology, Guizhou Medical University, Guiyang, Guizhou 550025, China."}, {"Identifier": [], "Affiliation": "Laboratory of Pathogenesis Research, Drug Prevention and Treatment of Major Diseases, Guizhou Medical University, Guiyang, Guizhou 550025, China."}], "LastName": "Zhou", "ForeName": "XingCheng", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pathophysiology, Guizhou Medical University, Guiyang, Guizhou 550025, China."}, {"Identifier": [], "Affiliation": "Laboratory of Pathogenesis Research, Drug Prevention and Treatment of Major Diseases, Guizhou Medical University, Guiyang, Guizhou 550025, China."}], "LastName": "Xiao", "ForeName": "Ying", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, Guizhou 550025, China."}, {"Identifier": [], "Affiliation": "Department of Pathophysiology, Guizhou Medical University, Guiyang, Guizhou 550025, China."}], "LastName": "Guo", "ForeName": "Bing", "Initials": "B"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Biosci Rep", "NlmUniqueID": "8102797", "ISSNLinking": "0144-8463"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Blood Glucose"}, {"RegistryNumber": "0", "NameOfSubstance": "Intercellular Signaling Peptides and Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "MIRN27 microRNA, rat"}, {"RegistryNumber": "0", "NameOfSubstance": "Membrane Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "MicroRNAs"}, {"RegistryNumber": "0", "NameOfSubstance": "Sfrp1 protein, rat"}, {"RegistryNumber": "5W494URQ81", "NameOfSubstance": "Streptozocin"}, {"RegistryNumber": "IY9XDZ35W2", "NameOfSubstance": "Glucose"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["metabolism"], "DescriptorName": "Blood Glucose"}, {"QualifierName": [], "DescriptorName": "Cell Line"}, {"QualifierName": ["blood", "chemically induced"], "DescriptorName": "Diabetes Mellitus, Experimental"}, {"QualifierName": ["etiology", "genetics", "metabolism", "pathology"], "DescriptorName": "Diabetic Nephropathies"}, {"QualifierName": ["drug effects", "metabolism", "pathology"], "DescriptorName": "Extracellular Matrix"}, {"QualifierName": [], "DescriptorName": "Fibrosis"}, {"QualifierName": ["toxicity"], "DescriptorName": "Glucose"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "Intercellular Signaling Peptides and Proteins"}, {"QualifierName": ["drug effects", "metabolism", "pathology"], "DescriptorName": "Kidney"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "Membrane Proteins"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "MicroRNAs"}, {"QualifierName": [], "DescriptorName": "Rats, Sprague-Dawley"}, {"QualifierName": [], "DescriptorName": "Streptozocin"}, {"QualifierName": ["drug effects"], "DescriptorName": "Wnt Signaling Pathway"}], "CoiStatement": "The authors declare that there are no competing interests associated with the manuscript."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "IDF Diabetes Atlas  (2017) medlive.cn. Accessed 1 December 2017 http://news.medlive.cn/endocr/info-progress/show-136057_46.html"}, {"Citation": "Li F., Chong Z. and Maiese K. (2006) Winding through the WNT pathway during cellular development and demisp. Histol. Histopathol. 21, 103\u2013124", "ArticleIdList": ["PMC2247407", "16267791"]}, {"Citation": "Maiese K., Li F., Chong Z. and Shang Y. (2008) The Wnt signalling pathway: aging gracefully as a protectionist. Pharmacol. Ther. 118, 58\u201381 10.1016/j.pharmthera.2008.01.004", "ArticleIdList": ["10.1016/j.pharmthera.2008.01.004", "PMC2432088", "18313758"]}, {"Citation": "He M., Wang Z., Hu W., Wang K., Wang D., Fang Z. et al. . (2019) Golgi Phosphoprotein 3 Promotes Malignant Phenotypes via FAK/Raf/MEK and Wnt/\u03b2-Catenin Signalling Pathways in Human Renal Cell Carcinoma. J. Biomed. Nanotechnol. 15, 1812\u20131823 10.1166/jbn.2019.2804", "ArticleIdList": ["10.1166/jbn.2019.2804", "31219012"]}, {"Citation": "Zhang X., Fang J., Chen Z., Zhao B., Wu S. and Pan Y. (2019) Qingshen Buyang Formula Attenuates Renal Fibrosis in 5/6 Nephrectomized Rats via Inhibiting EMT and Wnt/\u03b2-Catenin Pathway. Evid. Based Complement. Alternat. Med. 2, 1\u20139", "ArticleIdList": ["PMC6521559", "31186661"]}, {"Citation": "Zhang X., Chen X., Li D., Qi G., Dai Y., Gu J. et al. . (2019) Inhibition of miR-155 Ameliorates Acute Kidney Injury by Apoptosis Involving the Regulation on TCF4/Wnt/\u03b2-Catenin Pathway. Nephron 6, 1\u201313", "ArticleIdList": ["31216555"]}, {"Citation": "Cruciat C.M. and Niehrs C. (2103) Secreted and transmembrane Wnt inhibitors and activators. Cold Spring Harb. Perspect. Biol. 5, 1\u201326", "ArticleIdList": ["PMC3578365", "23085770"]}, {"Citation": "Elzi D., Song M., Hakala K., Weintraub S. and Shiio Y. (2012) Wnt antagonist SFRP1 functions as a secreted mediator of senescence. Mol. Cell. Biol. 32, 4388\u20134399 10.1128/MCB.06023-11", "ArticleIdList": ["10.1128/MCB.06023-11", "PMC3486147", "22927647"]}, {"Citation": "Xie Q., Chen L., Shan X., Tang J., Zhou F., Chen Q. et al. . (2014) Epigenetic silencing of SFRP1 and SFRP5 by hepatitis B virusX protein enhances hepatoma cell tumorigenicity throughWnt signalling pathway. Int. J. Cancer 135, 635\u2013646 10.1002/ijc.28697", "ArticleIdList": ["10.1002/ijc.28697", "24374650"]}, {"Citation": "Strzelczyk J.K., Krakowczyk \u0141 and Owczarek A.J. (2018) Methylation status of SFRP1, SFRP2, RASSF1A, RAR\u03b2 and DAPK1 genes in patients with oral squamous cell carcinoma. Arch. Oral. Biol. 98, 265\u2013272 10.1016/j.archoralbio.2018.12.001", "ArticleIdList": ["10.1016/j.archoralbio.2018.12.001", "30576962"]}, {"Citation": "Qiao B., He B., Cai J., Tao Q. and King-Yin Lam A. (2017) MicroRNA-27a-3p Modulates the Wnt/\u03b2-Catenin Signalling Pathway to Promote Epithelial Mesenchymal Transition in Oral Squamous Carcinoma Stem Cells by Targeting SFRP1. Sci. Rep. 20, 44688 10.1038/srep44688", "ArticleIdList": ["10.1038/srep44688", "PMC5397903", "28425477"]}, {"Citation": "Wang K., Xie D., Xie J., Wan Y., Ma L., Qi X. et al. . (2015) MiR-27a regulates Wnt/beta-catenin signalling through targeting SFRP1 in glioma Cellular. Neuroreport. 26, 695\u2013702 10.1097/WNR.0000000000000410", "ArticleIdList": ["10.1097/WNR.0000000000000410", "26164457"]}, {"Citation": "Bartel D.P. (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281\u2013297 10.1016/S0092-8674(04)00045-5", "ArticleIdList": ["10.1016/S0092-8674(04)00045-5", "14744438"]}, {"Citation": "Klein D., Misawa R., Bravo-Egana V., Vargas N., Rosero S., Piroso J. et al. . (2013) MicroRNA expression in alpha and beta cells of human pancreatic islets. PLoS ONE 8, 1\u20139 10.1371/journal.pone.0055064", "ArticleIdList": ["10.1371/journal.pone.0055064", "PMC3558471", "23383059"]}, {"Citation": "Farh K.K., Grimson A., Jan C., Lewis B.P., Johnston W.K., Lim L.P. et al. . (2005) The widespread impact of mammalian MicroRNAs on mRNA repression and evolution. Science 310, 1817\u20131821 10.1126/science.1121158", "ArticleIdList": ["10.1126/science.1121158", "16308420"]}, {"Citation": "Bhaskaran M. and Mohan M. (2014) MicroRNAs: history, biogenesis, and their evolving role in animal development and disease. Vet. Pathol. 51, 759\u2013774 10.1177/0300985813502820", "ArticleIdList": ["10.1177/0300985813502820", "PMC4013251", "24045890"]}, {"Citation": "Cui H.B., Ge H.E., Wang Y.S. and Bai X.Y. (2018) MiR-208a enhances cell proliferation and invasion of gastric cancer by targeting SFRP1 and negatively regulating MEG3. Int J Biochem Cell Biol. 102, 31\u201339 10.1016/j.biocel.2018.06.004", "ArticleIdList": ["10.1016/j.biocel.2018.06.004", "29886152"]}, {"Citation": "He F., Peng F., Xia X., Zhao C., Luo Q., Guan W. et al. . (2014) MiR-135a promotes renal fibrosis in diabetic nephropathy by regulating TRPC1. Diabetologia 57, 1726\u20131736 10.1007/s00125-014-3282-0", "ArticleIdList": ["10.1007/s00125-014-3282-0", "24908566"]}, {"Citation": "Zhang L., He S., Guo S., Xie W., Xin R., Yu H. et al. . (2014) Down-regulation of miR-34a alleviates mesangial proliferation in vitro and glomerular hypertrophy in early diabetic nephropathy mice by targeting GAS1. J. Diabetes Compl. 28, 259\u2013264 10.1016/j.jdiacomp.2014.01.002", "ArticleIdList": ["10.1016/j.jdiacomp.2014.01.002", "PMC4087162", "24560136"]}, {"Citation": "Cai J., Guan H., Fang L., Yang Y., Zhu X., Yuan J. et al. . (2013) MicroRNA-374a activates Wnt/\u03b2-catenin signalling to promote breast cancer metastasis. J. Clin. Invest. 123, 566\u2013579", "ArticleIdList": ["PMC3561816", "23321667"]}, {"Citation": "Barutta F., Tricarico M., Corbelli A., Annaratone L., Pinach S., Grimaldi S. et al. . (2013) Urinary exosomal microRNAs in incipient diabetic nephropathy. PLoS ONE 8, 1\u20138 10.1371/journal.pone.0073798", "ArticleIdList": ["10.1371/journal.pone.0073798", "PMC3817183", "24223694"]}, {"Citation": "Wu L., Wang Q., Guo F., Ma X., Ji H., Liu F. et al. . (2016) MicroRNA-27a Induces Mesangial Cell Injury by Targeting of PPAR\u03b3, and its In Vivo Knockdown Prevents Progression of Diabetic Nephropathy. Sci. Rep. 17, 1\u201312", "ArticleIdList": ["PMC4869109", "27184517"]}, {"Citation": "Wu J., Zheng C., Fan Y., Zeng C., Chen Z., Qin W. et al. . (2014) Downregulation of microRNA-30 facilitates podocyte injury and is prevented by glucocorticoids. J. Am. Soc. Nephrol. 25, 92\u2013104 10.1681/ASN.2012111101", "ArticleIdList": ["10.1681/ASN.2012111101", "PMC3871768", "24029422"]}, {"Citation": "Yuan H., Zhang X., Zheng W., Zhou H., Zhang B.Y. and Zhao D. (2016) Minocycline Attenuates Kidney Injury in a Rat Model of Streptozotocin Induced Diabetic Nephropathy. Biol. Pharm. Bull. 39, 1231\u20131237", "ArticleIdList": ["27476934"]}, {"Citation": "Qian L., Hong J., Zhang Y., Zhu M., Wang X., Zhang Y. et al. . (2018) Downregulation of S100A4 Alleviates Cardiac Fibrosis via Wnt/\u03b2-Catenin Pathway in Mice. Cell Physiol. Biochem. 46, 2551\u20132560 10.1159/000489683", "ArticleIdList": ["10.1159/000489683", "29758552"]}, {"Citation": "Hosseinzadeh A., Javad-Moosavi S.A., Reiter R.J., Hemati K., Ghaznavi H. and Mehrzadi S. (2018) Idiopathic pulmonary fibrosis (IPF) signalling pathways and protective roles of melatonin. Life Sci. 201, 17\u201329 10.1016/j.lfs.2018.03.032", "ArticleIdList": ["10.1016/j.lfs.2018.03.032", "29567077"]}, {"Citation": "Yu Y., Guan X., Nie L., Liu Y., He T., Xiong J. et al. . (2017) DNA hypermethylation of sFRP5 contributes to indoxyl sulfate-induced renal fibrosis. J. Mol. Med. (Berl.). 95, 601\u2013613 10.1007/s00109-017-1538-0", "ArticleIdList": ["10.1007/s00109-017-1538-0", "28508124"]}, {"Citation": "Sun H., Chen G., Wen B., Sun J., An H., Pang J. et al. . (2018) Oligo-peptide I-C-F-6 inhibits hepatic stellate cell activation and ameliorates CCl4-induced liver fibrosis by suppressing NF-\u03baB signalling and Wnt/\u03b2-catenin signaling. J. Pharmacol. Sci. 136, 133\u2013141 10.1016/j.jphs.2018.01.003", "ArticleIdList": ["10.1016/j.jphs.2018.01.003", "29501581"]}, {"Citation": "Lu Y., Zhang T., Shan S., Wang S., Bian W., Ren T. et al. . (2019) MiR-124 regulates transforming growth factor-\u03b21 induced differentiation of lung resident mesenchymal stem cells to myofibroblast by repressing Wnt/\u03b2-catenin signalling. Dev. Biol. 449, 115\u2013121 10.1016/j.ydbio.2019.02.010", "ArticleIdList": ["10.1016/j.ydbio.2019.02.010", "30802451"]}, {"Citation": "He W., Dai C., Li Y., Zeng G., Monga S.P. and Liu Y. (2009) Wnt/beta-catenin signalling promotes renal interstitial fibrosis. J. Am. Soc. Nephrol. 20, 765\u2013776 10.1681/ASN.2008060566", "ArticleIdList": ["10.1681/ASN.2008060566", "PMC2663839", "19297557"]}, {"Citation": "Ge W.S., Wang Y.J., Wu J.X., Fan J.G., Chen Y.W. and Zhu L. (2014) \u03b2-catenin is overexpressed in hepatic fibrosis and blockage of Wnt/\u03b2-catenin signalling inhibits hepatic stellate cell activation. Mol. Med. Rep. 9, 2145\u20132151 10.3892/mmr.2014.2099", "ArticleIdList": ["10.3892/mmr.2014.2099", "PMC4055486", "24691643"]}, {"Citation": "Zhang H., Zhu Y.Q., Wu Y.Q., Zhang P. and Qi J. (2014) Detection of promoter hypermethylation of Wnt antagonist genes in fecal samples for diagnosis of early colorectal cancer. World J. Gastroenterol. 20, 6329\u20136335 10.3748/wjg.v20.i20.6329", "ArticleIdList": ["10.3748/wjg.v20.i20.6329", "PMC4033472", "24876755"]}, {"Citation": "Huang J., Zhang Y.L., Teng X.M., Lin Y., Zheng D.L., Yang P.Y. et al. . (2007) Down-regulation of SFRP1as a putative tumour suppressor gene can contribute to human hepatocellular carcinoma. BMC Cancer 7, 126 10.1186/1471-2407-7-126", "ArticleIdList": ["10.1186/1471-2407-7-126", "PMC1940018", "17626620"]}, {"Citation": "Kim J. and Kim S. (2014) In silico Identification of SFRP1 as a Hypermethylated Gene in Colorectal Cancers. Genomics Inform. 12, 171\u2013180 10.5808/GI.2014.12.4.171", "ArticleIdList": ["10.5808/GI.2014.12.4.171", "PMC4330251", "25705155"]}, {"Citation": "Wang X., Wang H., Bu R., Fei X., Zhao C. and Song Y. (2012) Methylation and aberrant expression of the Wntantagonist secreted Frizzled-related protein 1 in bladder cancer. Oncol. Lett. 4, 334\u2013338 10.3892/ol.2012.713", "ArticleIdList": ["10.3892/ol.2012.713", "PMC3402742", "22844380"]}, {"Citation": "Ren L., Chen H., Song J., Chen X., Lin C., Zhang X. et al. . (2019) MiR-454-3p-Mediated Wnt/\u03b2-catenin Signalling Antagonists Suppression Promotes Breast Cancer Metastasis. Theranostics 9, 449\u2013465 10.7150/thno.29055", "ArticleIdList": ["10.7150/thno.29055", "PMC6376193", "30809286"]}, {"Citation": "Song X.L., Huang B., Zhou B.W., Wang C., Liao Z.W., Yu Y. et al. . (2018) miR-1301-3p promotes prostate cancer stem cell expansion by targeting SFRP1 and GSK3\u03b2. Biomed. Pharmacother. 99, 369\u2013374 10.1016/j.biopha.2018.01.086", "ArticleIdList": ["10.1016/j.biopha.2018.01.086", "29358129"]}, {"Citation": "Li Z., Xu Z., Xie Q., Gao W., Xie J. and Zhou L. (2016) miR-1303 promotes the proliferation of neuroblastoma cell SH-SY5Y by targeting GSK3b and SFRP1. Biomed. Pharmacother. 83, 508\u2013513 10.1016/j.biopha.2016.07.010", "ArticleIdList": ["10.1016/j.biopha.2016.07.010", "27434867"]}, {"Citation": "Ba S., Xuan Y., Long Z.W., Chen H.Y. and Zheng S.S. (2017) MicroRNA-27a Promotes the Proliferation and Invasiveness of Colon Cancer Cells by Targeting SFRP1 through the Wnt/beta-Catenin Signalling Pathway. Cell. Physiol. Biochem. 42, 1920\u20131933 10.1159/000479610", "ArticleIdList": ["10.1159/000479610", "28772260"]}, {"Citation": "Ma L. (2016) MicroRNA and Metastasis. Adv. Cancer Res. 132, 165\u2013207 10.1016/bs.acr.2016.07.004", "ArticleIdList": ["10.1016/bs.acr.2016.07.004", "27613133"]}, {"Citation": "Zhang Y., Zhao S., Wu D., Liu X., Shi M., Wang Y. et al. . (2018) MicroRNA-22 Promotes Renal Tubulointerstitial Fibrosis by Targeting PTEN and Suppressing Autophagy in Diabetic Nephropathy. J. Diabetes Res. 2018, 1\u201311", "ArticleIdList": ["PMC5903315", "29850604"]}]}], "History": [{"Year": "2019", "Month": "8", "Day": "15"}, {"Year": "2020", "Month": "5", "Day": "28"}, {"Year": "2020", "Month": "5", "Day": "29"}, {"Year": "2020", "Month": "6", "Day": "3", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "3", "Day": "25", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "6", "Day": "3", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "6", "Day": "15"}], "PublicationStatus": "ppublish", "ArticleIdList": ["32484208", "PMC7295625", "10.1042/BSR20192794", "225114"]}}]}